Interestingly, higher sTREM2 concentrations were noted in cognitively normal individuals suspected of non-AD pathology (tau positive, amyloid negative) (Wang et al., 2022a), suggesting that sTREM2 elevation might more accurately indicate neuronal injury associated with tau rather than amyloid pathology. Here, MAPT is linked to Alzheimer disease.